The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER)

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
254
The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Positioned to Take Advantage of Growing Support, Legislative Changes

- Timing of expansion into CBD market correlated with passing of 2018 Farm Bill
- MORE Act decriminalizes marijuana, has passed the House
- Reclassification of cannabis by the UN may increase medical research, impact legalization efforts globally

Founded in 2012, The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER) quickly earned a reputation as one of the fastest-growing and most innovative lifestyle brands. Now a leading producer of premium bottled alkaline water, flavor-infused waters and CBD-infused products, WTER’s flagship product was a premium 8.8 pH balanced alkaline drinking water produced through an innovative, state-of-the-art proprietary electrolysis process.

In 2018, WTER became publicly traded thanks to a disciplined growth strategy that soon expanded into the CBD space. The timing was perfect for this new endeavor. The 2018 Farm Bill passed, and CBD had become a buzz word in the health and wellness industry. WTER partnered with Centuria Foods and launched A88CBD(TM) in 2020, a product line (https://nnw.fm/hekSl) that only uses CBD sourced from hemp lawfully grown and processed within the United States.

But the United States hasn’t always been supportive of CBD. In 1937 under the Marihuana Tax Act, all parts of the marijuana plant were made illegal. In 1970 under the Controlled Substances Act, cannabis of any kind was prohibited. That changed in 2018 with the Farm Bill’s passing.

The 2018 Farm Bill played a large part in WTER’s story and expansion by allowing for hemp cultivation and the selling of hemp products under 0.3 percent THC (https://nnw.fm/gERH9). As new bills make their way across the House and Senate floors, WTER is looking forward to what it means for the company and the industry at large. New bills could lead to the long-awaited FDA guidance on CBD-infused consumer products.

An example of this type of legislations is the Marijuana Opportunity Reinvestment and Expungement Act (MORE Act) of 2019, which passed the House and is now awaiting approval in the Senate and then the White House. This marks the first time that a federal legislative body has ever voted to decriminalize marijuana. If the MORE Act passes both House and Senate and the President’s desk, marijuana will be removed from the list of scheduled substances. Criminal penalties will also be removed (https://nnw.fm/MRG3U). This is a strong step forward in removing stigmas and creating therapeutic options for consumers.

In addition to decriminalizing marijuana, the bill will put into motion several other changes, including:

- The ability for cannabis-related businesses to acquire loans and services not previously available
- Cannabis will no longer be used as a reason to allow for deportation or the rejection of asylum claims
- Those in prison for marijuana charges will receive a sentencing review for potentially reduced sentencing
- Federal cannabis sales tax of 5% of the sale price to pay for opportunity grants for communities most impacted by the war on drugs

The MORE Act is a step toward legal cannabis diversity and inclusion. While the future of the bill remains in question, the fact that it has progressed as far as it has indicates significant progress for cannabis in both government and popular support.

And the growing acceptance and changes aren’t only being seen in the United States. The United Nations recently voted to reclassify cannabis as a less dangerous drug (https://nnw.fm/RwXUj). This change holds the potential to increase medical research into the therapeutic benefits and impact legalization efforts globally.

“With the apparent change in administration in the U.S., we believe that the FDA guidance on CBD will be forthcoming soon,” said WTER CEO Richard Wright (https://nnw.fm/ssx7R). “Being the National Consumer Products goods company, we feel we are positioned very well to take advantage of any changes that would allow us to sell in all the states.”

For more information, visit the company’s website at www.TheAlkalineWaterCo.com.

NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://nnw.fm/WTER

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

Alkaline Water Company Inc. (WTER) Stock Research Links

WTER Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 170

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 108

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 358

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 336

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 364

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 86

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 372

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 64

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading

Top 5 Most Recently Viewed Articles

Analyzing Trump's Executive Orders and Their Economic Impact

Updated Category News Views 806

Executive Orders: A Shift in Economic Paradigms President Trump has taken significant steps by issuing a number of executive orders that have raised eyebrows among economists and market analysts alike. According to market expert Louis Navellier, this approach can be characterized as 'shock and awe'. It reflects a bold strategy that could reshape various aspects of the...

Continue Reading
B2PRIME Expands Institutional Reach with Stuart Brock's Addition

Updated Category News Views 173

B2PRIME Welcomes Stuart Brock as Institutional Business Development Manager B2PRIME Group, a leading financial services provider for institutional and professional clients, recently announced the appointment of Stuart Brock as its Institutional Business Development Manager. With over 15 years of experience in electronic trading and institutional sales, Stuart is poised to...

Continue Reading
United Parks & Resorts Inc. Shares Q1 2025 Financial Insights

Updated Category News Views 374

Financial Overview of United Parks & Resorts Inc. United Parks & Resorts Inc. (NYSE: PRKS), a prominent player in the theme park and entertainment sector, has recently shared its financial results for the first quarter of 2025. This report delves into the key metrics and operational insights that define the company’s performance in this period. Attendance and Revenue...

Continue Reading
Seongnam Pavilion Sets New Benchmark at CES 2025 with 41 Companies

Updated Category News Views 178

Seongnam Pavilion Makes Waves at CES 2025 At the latest CES 2025, Seongnam City showcased an impressive turnout at the world's leading consumer electronics exhibition. This year, Seongnam participated with a remarkable delegation of 41 companies, marking the largest participation ever. Focused on enhancing their global footprint, these small and medium-sized enterprises...

Continue Reading
Gaucho Holdings Seizes Opportunities Amid Argentina's Economic Revival

Updated Category News Views 179

Gaucho Holdings and the New Economic Landscape in Argentina Recently, Argentina has entered a new chapter of economic transformation. A shift in leadership, with Javier Milei becoming president, has sparked hopes for fiscal discipline, growth, and development. As the country embraces pro-market reforms, Gaucho Group Holdings, Inc. (NASDAQ: VINO) positions itself to...

Continue Reading